These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 33927259

  • 1. AntiTNF-alpha therapy normalizes levels of lipids and adipokines in psoriatic patients in the real-life settings.
    Olejniczak-Staruch I, Narbutt J, Ceryn J, Skibińska M, Bednarski I, Woźniacka A, Sieniawska J, Kraska-Gacka M, Ciążyńska M, Śmigielski J, Noweta M, Waszczykowski M, Owczarek W, Reich A, Lesiak A.
    Sci Rep; 2021 Apr 29; 11(1):9289. PubMed ID: 33927259
    [Abstract] [Full Text] [Related]

  • 2. Effects of TNF inhibitors and an IL12/23 inhibitor on changes in body weight and adipokine levels in psoriasis patients: a 48-week comparative study.
    Onsun N, Akaslan TÇ, Sallahoglu K, Gülcan AS, Bulut H, Yabacı A.
    J Dermatolog Treat; 2022 May 29; 33(3):1727-1732. PubMed ID: 33704001
    [Abstract] [Full Text] [Related]

  • 3. Serum levels of adipocytokines in psoriasis patients receiving tumor necrosis factor-α inhibitors: results of a retrospective analysis.
    Campanati A, Ganzetti G, Giuliodori K, Marra M, Bonfigli A, Testa R, Offidani A.
    Int J Dermatol; 2015 Jul 29; 54(7):839-45. PubMed ID: 25877149
    [Abstract] [Full Text] [Related]

  • 4. Anti-TNF-α Drugs Differently Affect the TNFα-sTNFR System and Monocyte Subsets in Patients with Psoriasis.
    Gibellini L, De Biasi S, Bianchini E, Bartolomeo R, Fabiano A, Manfredini M, Ferrari F, Albertini G, Trenti T, Nasi M, Pinti M, Iannone A, Salvarani C, Cossarizza A, Pellacani G.
    PLoS One; 2016 Jul 29; 11(12):e0167757. PubMed ID: 27936119
    [Abstract] [Full Text] [Related]

  • 5. Relationship of leptin with adiposity and inflammation and resistin with disease severity in psoriatic patients undergoing anti-TNF-alpha therapy.
    Pina T, Genre F, Lopez-Mejias R, Armesto S, Ubilla B, Mijares V, Dierssen-Sotos T, Gonzalez-Lopez MA, Gonzalez-Vela MC, Blanco R, Hernández JL, Llorca J, Gonzalez-Gay MA.
    J Eur Acad Dermatol Venereol; 2015 Oct 29; 29(10):1995-2001. PubMed ID: 25823684
    [Abstract] [Full Text] [Related]

  • 6. Presence of antidrug antibodies correlates inversely with the plasma tumor necrosis factor (TNF)-α level and the efficacy of TNF-inhibitor therapy in psoriasis.
    Kui R, Gál B, Gaál M, Kiss M, Kemény L, Gyulai R.
    J Dermatol; 2016 Sep 29; 43(9):1018-23. PubMed ID: 26892625
    [Abstract] [Full Text] [Related]

  • 7. TNF-α in a molecularly targeted therapy of psoriasis and psoriatic arthritis.
    Wcisło-Dziadecka D, Zbiciak-Nylec M, Brzezińska-Wcisło L, Mazurek U.
    Postgrad Med J; 2016 Mar 29; 92(1085):172-8. PubMed ID: 26719452
    [Abstract] [Full Text] [Related]

  • 8. Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey.
    Potenza MC, Peris K, Berardesca E, Bianchi L, Richetta A, Bernardini N, De Simone C, Teoli M, Zangrilli A, D'epiro S, Orsini D, Narcisi A, Chimenti S, Costanzo A.
    Dermatol Ther; 2018 Jan 29; 31(1):. PubMed ID: 29215183
    [Abstract] [Full Text] [Related]

  • 9. Etanercept for patients with psoriasis who did not respond or who lost their response to adalimumab or infliximab.
    Bissonnette R, Maari C, Barber K, Lynde CW, Vender R.
    J Eur Acad Dermatol Venereol; 2015 Aug 29; 29(8):1576-81. PubMed ID: 25600828
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of biologic therapies in psoriasis vulgaris.
    Mala R, Fida M, Jorgaqi E, Vasili E.
    Dermatol Ther; 2019 Jul 29; 32(4):e12936. PubMed ID: 30983095
    [Abstract] [Full Text] [Related]

  • 11. Biologic response modifiers and pediatric psoriasis.
    Bellodi Schmidt F, Shah KN.
    Pediatr Dermatol; 2015 Jul 29; 32(3):303-20. PubMed ID: 25727936
    [Abstract] [Full Text] [Related]

  • 12. Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset "sine psoriasis".
    Caso F, Postiglione L, Covelli B, Ricciardone M, Di Spigna G, Formisano P, D'Esposito V, Girolimetto N, Tasso M, Peluso R, Navarini L, Ciccozzi M, Margiotta DPE, Oliviero F, Afeltra A, Punzi L, Del Puente A, Scarpa R, Costa L.
    Clin Rheumatol; 2019 Sep 29; 38(9):2547-2552. PubMed ID: 31147798
    [Abstract] [Full Text] [Related]

  • 13. Biologic drug survival in Israeli psoriasis patients.
    Shalom G, Cohen AD, Ziv M, Eran CB, Feldhamer I, Freud T, Berman E, Oren S, Hodak E, Pavlovsky L.
    J Am Acad Dermatol; 2017 Apr 29; 76(4):662-669.e1. PubMed ID: 28038888
    [Abstract] [Full Text] [Related]

  • 14. Dose Modification in Biologic Therapy for Moderate to Severe Psoriasis: A Descriptive Analysis in a Clinical Practice Setting.
    Baniandrés O, Rodríguez-Soria VJ, Romero-Jiménez RM, Suárez R.
    Actas Dermosifiliogr; 2015 Sep 29; 106(7):569-77. PubMed ID: 25935194
    [Abstract] [Full Text] [Related]

  • 15. Biological therapies for psoriasis: Adherence and outcome analysis from a clinical perspective.
    Ross C, Marshman G, Grillo M, Stanford T.
    Australas J Dermatol; 2016 May 29; 57(2):137-40. PubMed ID: 25754697
    [Abstract] [Full Text] [Related]

  • 16. Changes in Body Mass Index and Lipid Profile in Psoriatic Patients After Treatment With Standard Protocol of Infliximab.
    Ehsani AH, Mortazavi H, Balighi K, Hosseini MS, Azizpour A, Hejazi SP, Goodarzi A, Darvari SB.
    Acta Med Iran; 2016 Sep 29; 54(9):570-575. PubMed ID: 27832688
    [Abstract] [Full Text] [Related]

  • 17. Serum leptin, adiponectin, resistin and ghrelin levels in psoriatic patients treated with cyclosporin.
    Ozdemir M, Yüksel M, Gökbel H, Okudan N, Mevlitoğlu I.
    J Dermatol; 2012 May 29; 39(5):443-8. PubMed ID: 22300284
    [Abstract] [Full Text] [Related]

  • 18. Serum chemerin is increased in patients with chronic plaque psoriasis and normalizes following treatment with infliximab.
    Gisondi P, Lora V, Bonauguri C, Russo A, Lippi G, Girolomoni G.
    Br J Dermatol; 2013 Apr 29; 168(4):749-55. PubMed ID: 23110708
    [Abstract] [Full Text] [Related]

  • 19. Paradoxical onset of psoriatic arthritis during treatment with biologic agents for plaque psoriasis: a combined dermatology and rheumatology clinical study.
    Napolitano M, Balato N, Caso F, Costa L, Megna M, Cirillo T, Balato A, Scarpa R.
    Clin Exp Rheumatol; 2017 Apr 29; 35(1):137-140. PubMed ID: 27749221
    [Abstract] [Full Text] [Related]

  • 20. TNF inhibitors for psoriasis.
    Chima M, Lebwohl M.
    Semin Cutan Med Surg; 2018 Sep 29; 37(3):134-142. PubMed ID: 30215629
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.